Women are twice as likely to be affected by dementia ...

New research suggests that an existing blood test may help to determine when someone is likely to develop Alzheimer's disease ...

UC San Diego researchers found a blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear, according to a paper published Tuesday.

Experts in the US found that higher levels of a protein called p-tau217 were an accurate predictor of people developing cognitive problems and dementia.

Diagnostic tests are continuing to get better at spotting the earliest signs of dementia, and new research suggests that a simple blood sample could help identify those at most risk, some 25 years ...

Scientists develop a blood test that detects Alzheimer’s by measuring protein structural changes rather than protein quantity.

A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...

The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

Scientists found that a blood protein called p tau217 may reveal dementia risk up to 25 years before symptoms appear.